Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

key information

study id #: NCT00510692

condition: Familial Adenomatous Polyposis Coli, FAP

status: completed


This purpose of this study is to investigate whether the number and size of rectal polyps can be reduced in patients with Familial Adenomatous Polyposis (FAP) by using a highly-purified form of a naturally occurring substance, the omega-3 fatty acid, eicosapentaenoic acid (EPA).

Drug: Eicosapentanoic Acid (EPA)
Procedure: Endoscopy
Procedure: Biopsies taken
Drug: Placebo

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.